Flying The Web For News.
  • New Year's
    New Year's
  • Career Exam Study
    Career Exam Study
  • 2024 Presidential Election
    2024 Presidential Election
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News
+ Larger Font | - Smaller Font
Share

Globe NewsWire News Distribution Service


If you suffered losses exceeding $50,000 in Bolt between February 5, 2021 and May 14, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/BOLT.


Posted: 2024-07-26 16:05:00

Get Full News Story On GlobeNewsWire Press Release Service



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.



Related News Stories From The Web And More

Related Bing News Search Results

Press Release: SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt - Newscast

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims On Behalf Of Investors Of Humacyte

Thu, 02 Jan 2025 00:16:00 GMT On August 9, 2024, after the market closed, Humacyte issued a press release ... or not. Faruqi & Faruqi, LLP also encourages anyone with information Humacyte's conduct to contact the firm, including ...

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lilium N.V

Wed, 01 Jan 2025 09:59:00 GMT If you suffered losses exceeding $50,000 in Lilium between June 11, 2024 and November 3, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at ...

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

Wed, 01 Jan 2025 09:28:00 GMT On June 2, 2024, Caribou issued a press release announcing that it had "presented updated clinical data from the ongoing ANTLER Phase 1 trial that [purportedly] indicates a single dose of CB-010 . . .

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca

Wed, 01 Jan 2025 09:06:00 GMT If you suffered losses exceeding $100,000 in AstraZeneca between between February 23, 2022 and December 17, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson ...

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aehr Test Systems

Wed, 01 Jan 2025 08:00:00 GMT If you suffered losses exceeding $50,000 in Aehr between January 9, 2024 and March 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at ...


Blow Us A Whistle